|
Doris Taylor PhD, FACC, FAHA, FESC, FAIMBE
CEO
Organamet Bio
|
Doris Taylor undertook the first cell therapy in heart in 1998. She is a pioneer and global thought leader in regenerative medicine holding over 20 patents in the field. She is credited with the first scientific repair of injured heart with stem cells in 1998. Her group further transformed the field of organ transplantation science in 2008 by developing a unique cell removal (decellularization) method that makes un-transplantable organs into usable scaffold frameworks for building new organs with stem cells. This was so revolutionary it was recognized as one of the “Top 10 Research Advances” by the American Heart Association and Taylor was nominated as one of “100 most influential people in the world” by Time magazine. Next, she turned to disease prevention and has begun to develop “cellular signatures” of heart disease and aging that appear to differ by sex, race and ethnicity.
Taylor is passionate about creating cures for heart disease, which kills more people worldwide than any other disease and has an estimated economic impact of 219 billion dollars annually. In 2021, Taylor co-founded a new biotech in, Organamet Bio Inc. whose mission is to cure heart disease and reduce healthcare costs. Her first goal is to bioengineer personalized replacement hearts on demand. She is equally committed to making those therapies available fairly, equitably, and as soon as they are shown to be safe and effective.
With a career spanning over 3 decades at the forefront of the field, Dr. Taylor frequently appears as an expert on cell therapy, women’s health, cardiac repair and organ transplantation in the public media. Her work has been recognized and featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, Forbes, National Geographic, BBC Horizon, BBC News Health, ABC, NBC and CBS News, Associated Press, Good Morning America, NOVA Science Now, PBS NOVA Transplanting Hope, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, NPR’s On Being with Krista Tippet, Sanjay Gupta’s Champions for Change and most other worldwide media outlets.
Taylor has sat on numerous think tanks and international scientific committees including for the NIH, the FDA, the American Association of Blood Banks, and the Alliance for Regenerative Medicine. She is a member of the Leadership Advisory Committee for the Advanced Regenerative Manufacturing Institute (ARMI) and sat for almost 2 decades on the international jury for the Institut de France LeFoulon-Delalande Foundation Grand Prix which is awarded annually to individuals making worldwide contributions to cardiovascular medicine.
Dr. Taylor earned a B.S. from Mississippi University for Women (MUW) and a Ph.D. from UT Southwestern Medical Center. She is appointed as a Fellow of the American Heart Association, American College of Cardiology, and European Society for Cardiology. She was awarded an honorary Doctor of Science degree by MUW and the national Distinguished Alumnus Award by the American Association of State Colleges and Universities. In 2019 she was elected as a Senior member of the National Academy of Inventors and in 2020, was elected as a fellow to the American Institute for Medical and Biological Engineering.
Her motto is, “Build the Future Today – and Do It With Heart.”
Taylor is passionate about creating cures for heart disease, which kills more people worldwide than any other disease and has an estimated economic impact of 219 billion dollars annually. In 2021, Taylor co-founded a new biotech in, Organamet Bio Inc. whose mission is to cure heart disease and reduce healthcare costs. Her first goal is to bioengineer personalized replacement hearts on demand. She is equally committed to making those therapies available fairly, equitably, and as soon as they are shown to be safe and effective.
With a career spanning over 3 decades at the forefront of the field, Dr. Taylor frequently appears as an expert on cell therapy, women’s health, cardiac repair and organ transplantation in the public media. Her work has been recognized and featured by 60 Minutes, CNN, The New York Times, The Wall Street Journal, Forbes, National Geographic, BBC Horizon, BBC News Health, ABC, NBC and CBS News, Associated Press, Good Morning America, NOVA Science Now, PBS NOVA Transplanting Hope, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, NPR’s On Being with Krista Tippet, Sanjay Gupta’s Champions for Change and most other worldwide media outlets.
Taylor has sat on numerous think tanks and international scientific committees including for the NIH, the FDA, the American Association of Blood Banks, and the Alliance for Regenerative Medicine. She is a member of the Leadership Advisory Committee for the Advanced Regenerative Manufacturing Institute (ARMI) and sat for almost 2 decades on the international jury for the Institut de France LeFoulon-Delalande Foundation Grand Prix which is awarded annually to individuals making worldwide contributions to cardiovascular medicine.
Dr. Taylor earned a B.S. from Mississippi University for Women (MUW) and a Ph.D. from UT Southwestern Medical Center. She is appointed as a Fellow of the American Heart Association, American College of Cardiology, and European Society for Cardiology. She was awarded an honorary Doctor of Science degree by MUW and the national Distinguished Alumnus Award by the American Association of State Colleges and Universities. In 2019 she was elected as a Senior member of the National Academy of Inventors and in 2020, was elected as a fellow to the American Institute for Medical and Biological Engineering.
Her motto is, “Build the Future Today – and Do It With Heart.”